{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":74,"mapped":1},"pagination":{"has_next":false},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"Q9NZQ7","source":"Q9NZQ7|Programmed cell death 1 ligand 1","targets":["3BIK|Crystal Structure of the PD-1/PD-L1 Complex|X-RAY DIFFRACTION|2.65|Homo sapiens; Mus musculus|0|IMMUNE SYSTEM","3BIS|Crystal Structure of the PD-L1|X-RAY DIFFRACTION|2.64|Homo sapiens|0|IMMUNE SYSTEM","3FN3|Dimeric Structure of PD-L1|X-RAY DIFFRACTION|2.7|Homo sapiens|0|IMMUNE SYSTEM","3SBW|Crystal structure of the complex between the extracellular domains of mouse PD-1 mutant and human PD-L1|X-RAY DIFFRACTION|2.28|Homo sapiens; Mus musculus|0|IMMUNE SYSTEM","4Z18|CRYSTAL STRUCTURE OF HUMAN PD-L1|X-RAY DIFFRACTION|1.952|Homo sapiens|0|SIGNALING PROTEIN","4ZQK|Structure of the complex of human programmed death-1 (PD-1) and its ligand PD-L1.|X-RAY DIFFRACTION|2.45|Homo sapiens|0|IMMUNE SYSTEM","5C3T|PD-1 binding domain from human PD-L1|X-RAY DIFFRACTION|1.8|Homo sapiens|0|IMMUNE SYSTEM","5GGT|PD-L1 in complex with BMS-936559 Fab|X-RAY DIFFRACTION|2.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","5GRJ|Crystal structure of human PD-L1 with monoclonal antibody avelumab|X-RAY DIFFRACTION|3.206|Homo sapiens|0|IMMUNE SYSTEM","5IUS|Crystal structure of human PD-L1 in complex with high affinity PD-1 mutant|X-RAY DIFFRACTION|2.889|Homo sapiens|0|IMMUNE SYSTEM","5J89|Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor|X-RAY DIFFRACTION|2.2|Homo sapiens|0|IMMUNE SYSTEM","5J8O|Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor|X-RAY DIFFRACTION|2.3|Homo sapiens|0|IMMUNE SYSTEM","5JDR|Structure of PD-L1|X-RAY DIFFRACTION|2.7|Homo sapiens|0|IMMUNE SYSTEM","5JDS|Crystal structure of PD-L1 complexed with a nanobody at 1.7 Angstron resolution|X-RAY DIFFRACTION|1.7|Camelidae; Homo sapiens|0|IMMUNE SYSTEM","5N2D|Structure of PD-L1/small-molecule inhibitor complex|X-RAY DIFFRACTION|2.35|Homo sapiens|0|CELL CYCLE","5N2F|Structure of PD-L1/small-molecule inhibitor complex|X-RAY DIFFRACTION|1.7|Homo sapiens|0|IMMUNE SYSTEM","5NIU|Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor|X-RAY DIFFRACTION|2.01|Homo sapiens|0|IMMUNE SYSTEM","5O45|Structure of human PD-L1 in complex with inhibitor|X-RAY DIFFRACTION|0.99|Homo sapiens; SYNTHETIC CONSTRUCT|0|CELL CYCLE","5O4Y|Structure of human PD-L1 in complex with inhibitor|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|CELL CYCLE","5X8L|PD-L1 in complex with atezolizumab|X-RAY DIFFRACTION|3.1|Homo sapiens|0|IMMUNE SYSTEM","5X8M|PD-L1 in complex with durvalumab|X-RAY DIFFRACTION|2.661|Homo sapiens|0|IMMUNE SYSTEM","5XJ4|Complex structure of durvalumab-scFv/PD-L1|X-RAY DIFFRACTION|2.3|Homo sapiens|0|IMMUNE SYSTEM","5XXY|Crystal structure of PD-L1 complexed with atezolizumab fab at 2.9A|X-RAY DIFFRACTION|2.9|Homo sapiens|0|IMMUNE SYSTEM","6L8R|membrane-bound PD-L1-CD|SOLUTION NMR||Homo sapiens|0|IMMUNOSUPPRESSANT","6NM7|PD-L1 IgV domain bound to fragment|X-RAY DIFFRACTION|2.426|Homo sapiens|0|immune system/inhibitor","6NM8|IgV-V76T BMS compound 105|X-RAY DIFFRACTION|2.792|Homo sapiens|0|immune system/inhibitor","6NNV|PD-L1 IgV domain complex with macro-cyclic peptide|X-RAY DIFFRACTION|1.92|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","6NOJ|PD-L1 IgV domain V76T with fragment|X-RAY DIFFRACTION|2.33|Homo sapiens|0|IMMUNE SYSTEM","6NOS|PD-L1 IgV domain V76T with fragment|X-RAY DIFFRACTION|2.701|Homo sapiens|0|IMMUNE SYSTEM","6NP9|PD-L1 IgV domain V76T with fragment|X-RAY DIFFRACTION|1.27|Homo sapiens|0|IMMUNE SYSTEM","6PV9|Human PD-L1 bound to a macrocyclic peptide which blocks the PD-1/PD-L1 interaction|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","6R3K|Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor|X-RAY DIFFRACTION|2.2|Homo sapiens|0|IMMUNE SYSTEM","6RPG|Structure of human Programmed cell death 1 ligand 1 (PD-L1) with inhibitor|X-RAY DIFFRACTION|2.7|Homo sapiens|0|CELL CYCLE","6VQN|Co-crystal structure of human PD-L1 complexed with Compound A|X-RAY DIFFRACTION|2.49|Homo sapiens|0|CELL CYCLE","6YCR|Structure of human PD-L1 in complex with inhibitor|X-RAY DIFFRACTION|1.54|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","7BEA|Structure of human Programmed cell death 1 ligand 1 (PD-L1) with inhibitor|X-RAY DIFFRACTION|2.45|Homo sapiens|0|IMMUNE SYSTEM","7C88|Complex structure of JS003 and PD-L1|X-RAY DIFFRACTION|1.997|Homo sapiens; Mus musculus|0|IMMUNE SYSTEM","7CZD|Crystal structure of PD-L1 in complex with a VHH|X-RAY DIFFRACTION|1.64|Homo sapiens; Lama glama|0|IMMUNE SYSTEM","7DCV|Structure of the transmembrane domain of human PD-L1|SOLUTION NMR||Homo sapiens|0|IMMUNE SYSTEM","7DY7|Discovery of Novel Small-molecule Inhibitors of PD-1/PD-L1 Axis that Promotes PD-L1 Internalization and Degradation|X-RAY DIFFRACTION|2.42|Homo sapiens|0|IMMUNOSUPPRESSANT","7NLD|Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor|X-RAY DIFFRACTION|2.3|Homo sapiens|0|IMMUNE SYSTEM","7OUN|Structure of human PD-L1 in complex with macrocyclic inhibitor|X-RAY DIFFRACTION|1.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|CELL CYCLE","7SJQ|Ex silico engineering of cystine-dense peptides yielding a potent bispecific T-cell engager|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|ANTITUMOR PROTEIN","7TPS|Crystal structure of ALPN-202 (engineered CD80 vIgD) in complex with PD-L1|X-RAY DIFFRACTION|3.15|Homo sapiens|0|IMMUNE SYSTEM","7UX5|Structure of PDL1 in complex with FP28136, a Helicon Polypeptide|X-RAY DIFFRACTION|3.35|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","7UXO|Structure of PDL1 in complex with FP30790, a Helicon Polypeptide|X-RAY DIFFRACTION|2.25|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","7UXP|Structure of PDL1 in complex with FP28132, a Helicon Polypeptide|X-RAY DIFFRACTION|2.62|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","7UXQ|Structure of PDL1 in complex with FP28135, a Helicon Polypeptide|X-RAY DIFFRACTION|2.89|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","7VUN|Design, modification, evaluation and cocrystal studies of novel phthalimides regulating PD-1/PD-L1 interaction|X-RAY DIFFRACTION|2.701|Homo sapiens|0|STRUCTURAL PROTEIN","7XAD|Crystal strucutre of PD-L1 and DBL2_02 designed protein binder|X-RAY DIFFRACTION|3|chemical production metagenome; Homo sapiens|0|IMMUNE SYSTEM","7XAE|Crystal strucutre of PD-L1 and 3ONJA protein|X-RAY DIFFRACTION|3.44|chemical production metagenome; Homo sapiens|0|IMMUNE SYSTEM","7XYQ|Crystal strucutre of PD-L1 and the computationally designed DBL1_03 protein binder|X-RAY DIFFRACTION|2.85|Homo sapiens; synthetic construct|0|IMMUNE SYSTEM","7YDS|The structure of the bispecific antibody targeted PD-L1 and 4-1BB|X-RAY DIFFRACTION|2.3|Homo sapiens|0|IMMUNE SYSTEM","8ALX|Structure of human PD-L1 in complex with inhibitor|X-RAY DIFFRACTION|1.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","8AOK|Complex of PD-L1 with VHH6|X-RAY DIFFRACTION|1.6|Homo sapiens; Lama glama|0|IMMUNE SYSTEM","8AOM|Complex of PD-L1 with VHH1|X-RAY DIFFRACTION|2.202|Homo sapiens; Lama glama|0|IMMUNE SYSTEM","8JBA|Discovery and Crystallography Study of Novel Oxadiazole Analogs as Small Molecule PD-1/PD-L1 inhibitors|X-RAY DIFFRACTION|2.6|Homo sapiens|0|IMMUNE SYSTEM","8K5N|Discovery of Novel PD-L1 Inhibitors That Induce Dimerization and Degradation of PD-L1 Based on Fragment Coupling Strategy|X-RAY DIFFRACTION|2.2|Homo sapiens|0|IMMUNE SYSTEM","8OR1|Co-crystal strucutre of PD-L1 with low molecular weight inhibitor|X-RAY DIFFRACTION|3.5|Homo sapiens|0|IMMUNE SYSTEM","8P1O|Solubilizer tag effect on PD-L1/inhibitor binding properties for m-terphenyl derivatives|X-RAY DIFFRACTION|2.17|Homo sapiens|0|IMMUNE SYSTEM","8P64|Co-crystal structure of PD-L1 with low molecular weight inhibitor|X-RAY DIFFRACTION|3.312|Homo sapiens|0|ANTITUMOR PROTEIN","8RPB|Structure of S79 Fab in complex with IgV domain of human PD-L1|X-RAY DIFFRACTION|2.794|Homo sapiens|0|IMMUNE SYSTEM","8XR5|Crystal structure of PD-L1 complexed with small molecule inhibitor X18|X-RAY DIFFRACTION|1.95|Homo sapiens|0|IMMUNOSUPPRESSANT/INHIBITOR","8ZNL|PD-L1 de novo designed binder with picomolar binding affinity|X-RAY DIFFRACTION|1.77|Escherichia coli; Homo sapiens|0|DE NOVO PROTEIN","9EO0|Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1|X-RAY DIFFRACTION|2.5|Homo sapiens|0|ANTITUMOR PROTEIN","9ERY|Co-crystal strucutre of PD-L1 with low molecular weight inhibitor|X-RAY DIFFRACTION|2.7|Homo sapiens|0|IMMUNE SYSTEM","9HRT|Structure of human PD-L1 in complex with clinically evaluated inhibitor|X-RAY DIFFRACTION|2.3|Homo sapiens|0|IMMUNE SYSTEM","9I0U|Structure of human PD-L1 in complex with clinically evaluated inhibitor|X-RAY DIFFRACTION|1.46|Homo sapiens|0|IMMUNE SYSTEM","9I0W|Structure of human PD-L1 in complex with clinically evaluated inhibitor|X-RAY DIFFRACTION|2.1|Homo sapiens|0|IMMUNE SYSTEM","9IJT|Crystal Structure of human Programmed cell death 1 ligand 1 (PD-L1) bound to Small molecule inhibitor Compound-10|X-RAY DIFFRACTION|2.05|Homo sapiens|0|IMMUNE SYSTEM","9INU|Novel PD-L1/VISTA dual inhibitor as potential immunotherapy agents|X-RAY DIFFRACTION|2.7|Homo sapiens|0|IMMUNE SYSTEM","9LJ3|Crystal structure of P25|X-RAY DIFFRACTION|3.15|Homo sapiens|0|IMMUNE SYSTEM","9MAP|Crystal structure of GAGWLP and PD-L1|X-RAY DIFFRACTION|3|Homo sapiens|0|IMMUNE SYSTEM","8R6Q||||||"]}]}